1. Home
  2. LIDR vs INMB Comparison

LIDR vs INMB Comparison

Compare LIDR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.19

Market Cap

63.7M

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.01

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
INMB
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.7M
64.7M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
LIDR
INMB
Price
$1.19
$2.01
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$4.75
$5.40
AVG Volume (30 Days)
4.4M
326.7K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.85
EPS
N/A
N/A
Revenue
$233,000.00
$50,000.00
Revenue This Year
$2,604.29
N/A
Revenue Next Year
$466.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.35
257.14
52 Week Low
$1.01
$1.09
52 Week High
$4.00
$2.60

Technical Indicators

Market Signals
Indicator
LIDR
INMB
Relative Strength Index (RSI) 46.06 N/A
Support Level $1.16 N/A
Resistance Level $1.38 N/A
Average True Range (ATR) 0.06 0.00
MACD -0.01 0.00
Stochastic Oscillator 13.89 0.00

Price Performance

Historical Comparison
LIDR
INMB

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: